| Guilherme Godoy, MD | |
|
6620 Main St, Suite 1325, Ms Bcm380, Houston, TX 77030-2348 | |
| (713) 798-5628 | |
| (713) 798-5553 |
| Full Name | Guilherme Godoy |
|---|---|
| Gender | Male |
| Speciality | Urology |
| Experience | 25 Years |
| Location | 6620 Main St, Houston, Texas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013219328 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208800000X | Urology | P4448 (Texas) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Chi St Luke's Health Baylor College Of Medicine Me | Houston, TX | Hospital |
| Harris Health System | Houston, TX | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Baylor College Of Medicine | 8022243971 | 917 |
| Baylor College Of Medicine | 8224941265 | 684 |
News Archive
OBN and EMIG - organisations with a combined membership of approximately 570 emerging R&D companies in biotechnology and medical technology, and established small and mid-sized biopharmaceutical firms, respectively - have called on the UK government to allocate additional funding to support the industrial component of Innovate UK's Biomedical Catalyst (BMC).
Researchers at the Burnham Institute for Medical Research (Burnham) may have found a new option for targeted breast cancer therapy by showing the link between a certain protein and the formation and development of blood vessels that feed breast tumors.
A regional health authority in the UK will refuse to treat overweight people needing hip and knee replacements on the National Health Service.
EDAP TMS SA, the global leader in therapeutic ultrasound, announced today the European approval of its new lithotripter, the Sonolith i-move. The EDAP sales team and distributors will begin marketing Sonolith i-move immediately and will officially introduce the product to distributors, partners and visiting urologists at the European Association Urology (EAU) congress, Booth #14, from April 17-19, 2010 in Barcelona, Spain.
Gen-Probe Incorporated and Pacific Biosciences announced today that Gen-Probe has made a $50 million strategic investment in Pacific Biosciences, a private sequencing company. In addition, the companies will work together to explore co-development of new integrated clinical diagnostics systems based on Pacific Biosciences' Single Molecule Real Time (SMRT™) platform and Gen-Probe's expertise in diagnostics.
› Verified 6 days ago
| Entity Name | Baylor College Of Medicine |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1053352914 PECOS PAC ID: 8224941265 Enrollment ID: O20031106000562 |
News Archive
OBN and EMIG - organisations with a combined membership of approximately 570 emerging R&D companies in biotechnology and medical technology, and established small and mid-sized biopharmaceutical firms, respectively - have called on the UK government to allocate additional funding to support the industrial component of Innovate UK's Biomedical Catalyst (BMC).
Researchers at the Burnham Institute for Medical Research (Burnham) may have found a new option for targeted breast cancer therapy by showing the link between a certain protein and the formation and development of blood vessels that feed breast tumors.
A regional health authority in the UK will refuse to treat overweight people needing hip and knee replacements on the National Health Service.
EDAP TMS SA, the global leader in therapeutic ultrasound, announced today the European approval of its new lithotripter, the Sonolith i-move. The EDAP sales team and distributors will begin marketing Sonolith i-move immediately and will officially introduce the product to distributors, partners and visiting urologists at the European Association Urology (EAU) congress, Booth #14, from April 17-19, 2010 in Barcelona, Spain.
Gen-Probe Incorporated and Pacific Biosciences announced today that Gen-Probe has made a $50 million strategic investment in Pacific Biosciences, a private sequencing company. In addition, the companies will work together to explore co-development of new integrated clinical diagnostics systems based on Pacific Biosciences' Single Molecule Real Time (SMRT™) platform and Gen-Probe's expertise in diagnostics.
› Verified 6 days ago
| Entity Name | Baylor College Of Medicine |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1881026664 PECOS PAC ID: 8022243971 Enrollment ID: O20131030000972 |
News Archive
OBN and EMIG - organisations with a combined membership of approximately 570 emerging R&D companies in biotechnology and medical technology, and established small and mid-sized biopharmaceutical firms, respectively - have called on the UK government to allocate additional funding to support the industrial component of Innovate UK's Biomedical Catalyst (BMC).
Researchers at the Burnham Institute for Medical Research (Burnham) may have found a new option for targeted breast cancer therapy by showing the link between a certain protein and the formation and development of blood vessels that feed breast tumors.
A regional health authority in the UK will refuse to treat overweight people needing hip and knee replacements on the National Health Service.
EDAP TMS SA, the global leader in therapeutic ultrasound, announced today the European approval of its new lithotripter, the Sonolith i-move. The EDAP sales team and distributors will begin marketing Sonolith i-move immediately and will officially introduce the product to distributors, partners and visiting urologists at the European Association Urology (EAU) congress, Booth #14, from April 17-19, 2010 in Barcelona, Spain.
Gen-Probe Incorporated and Pacific Biosciences announced today that Gen-Probe has made a $50 million strategic investment in Pacific Biosciences, a private sequencing company. In addition, the companies will work together to explore co-development of new integrated clinical diagnostics systems based on Pacific Biosciences' Single Molecule Real Time (SMRT™) platform and Gen-Probe's expertise in diagnostics.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Guilherme Godoy, MD 6620 Main St, Suite 1325, Ms Bcm380, Houston, TX 77030-2348 Ph: (713) 798-5628 | Guilherme Godoy, MD 6620 Main St, Suite 1325, Ms Bcm380, Houston, TX 77030-2348 Ph: (713) 798-5628 |
News Archive
OBN and EMIG - organisations with a combined membership of approximately 570 emerging R&D companies in biotechnology and medical technology, and established small and mid-sized biopharmaceutical firms, respectively - have called on the UK government to allocate additional funding to support the industrial component of Innovate UK's Biomedical Catalyst (BMC).
Researchers at the Burnham Institute for Medical Research (Burnham) may have found a new option for targeted breast cancer therapy by showing the link between a certain protein and the formation and development of blood vessels that feed breast tumors.
A regional health authority in the UK will refuse to treat overweight people needing hip and knee replacements on the National Health Service.
EDAP TMS SA, the global leader in therapeutic ultrasound, announced today the European approval of its new lithotripter, the Sonolith i-move. The EDAP sales team and distributors will begin marketing Sonolith i-move immediately and will officially introduce the product to distributors, partners and visiting urologists at the European Association Urology (EAU) congress, Booth #14, from April 17-19, 2010 in Barcelona, Spain.
Gen-Probe Incorporated and Pacific Biosciences announced today that Gen-Probe has made a $50 million strategic investment in Pacific Biosciences, a private sequencing company. In addition, the companies will work together to explore co-development of new integrated clinical diagnostics systems based on Pacific Biosciences' Single Molecule Real Time (SMRT™) platform and Gen-Probe's expertise in diagnostics.
› Verified 6 days ago
Kelly Bree, M.D. Urology Medicare: Medicare Enrolled Practice Location: 1515 Holcombe Blvd, Houston, TX 77030 Phone: 713-792-6161 | |
Prof. Peter Phuc Hinh, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 1200 Binz St Ste 690, Houston, TX 77004 Phone: 713-366-7831 Fax: 713-482-5815 | |
Dr. Herbert L Watkins, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 1140 Westmont Dr Ste 425, Houston, TX 77015 Phone: 713-453-4395 Fax: 713-453-4397 | |
Dr. Kumaran Sathyamoorthy, MD, MPH Urology Medicare: Accepting Medicare Assignments Practice Location: 10425 Huffmeister Rd Ste 210, Houston, TX 77065 Phone: 281-890-0911 Fax: 281-890-0980 | |
Kevin G Nickell, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 7777 Southwest Fwy, # 1032, Houston, TX 77074 Phone: 713-351-0644 Fax: 713-351-0633 | |
Richard J. Babaian, M.D. Urology Medicare: Not Enrolled in Medicare Practice Location: 1515 Holcombe Blvd, Houston, TX 77030 Phone: 713-792-6161 |